article thumbnail

The Benefits of Integrated CDMO Services: Streamlining Drug Development and Manufacturing

Drug Patent Watch

This shift has led to the emergence of integrated contract development and manufacturing organizations (CDMOs), which provide end-to-end support for drug developers. Reshaping drug development through CRO/CDMO integration. billion in 2022 and is expected to grow at a compound annual growth rate of 5.3%

article thumbnail

How to Manage Generic Drug Development Timelines: Strategies for Success

Drug Patent Watch

Accelerating Generic Drug Development: Strategies for Success As a pharmaceutical professional, you know how crucial it is to navigate the complex landscape of generic drug development. The generic drug development process involves several stages, from patent research to regulatory approvals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

4 ways to bring COVID’s ‘warp speed’ to the next era of drug development

PharmaVoice

An IQVIA Institute for Human Data Science report outlines how companies can improve communication, recruitment, data and investing strategies to accelerate clinical trial timelines.

article thumbnail

FDA publishes paper on AI/ML in drug development

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has released a discussion paper to complement and inform future guidance on artificial intelligence (AI) and machine learning (ML) in drug development. The post FDA publishes paper on AI/ML in drug development appeared first on European Pharmaceutical Review.

article thumbnail

International regulation: the importance of quality assurance in drug development

European Pharmaceutical Review

As drug development professionals know, global health crises like the COVID-19 pandemic provide the public with valuable insights into how clinical research and regulatory processes work. What are the main challenges quality assurance and compliance professionals face during the drug development and review process?

article thumbnail

Engaging change: Connecting patients and regulators can move the dial on drug development

pharmaphorum

Regulators are increasingly asking drug developers to include the patient voice in submissions, but the best way to go about this is less clear-cut. It was held primarily to gain feedback from the community on the most important metrics in clinical trials, and how to move forward with specific trial endpoints.

article thumbnail

Birmingham University team finds new drug development approach

Pharmaceutical Technology

Researchers at the University of Birmingham have discovered a mechanism of enzyme communication that could aid drug development.